Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cerus Corporation - Common Stock (NQ:CERS)

1.580 -0.010 (-0.63%)
Official Closing Price Updated: 4:00 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cerus Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting
From Cerus Corporation
Via Business Wire
S&P 5000 Edges Higher; US Crude Oil Inventories Fall
 
Via Benzinga
Topics Stocks
Crude Oil Edges Higher; US Retail Sales Top Expectations
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
CSX Posts Weak Earnings, Joins Lucid Group, Nokia And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe
From Cerus Corporation
Via Business Wire
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
ZoomInfo Reports Weak Results, Joins Chegg And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
 
Via Benzinga
MercadoLibre Posts Upbeat Results, Joins Integral Ad Science, Willdan Group, Fresh Del Monte Produce And Other Big Stocks Moving Higher On Friday
 
Via Benzinga
Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024
From Cerus Corporation
Via Business Wire
ASML Reports Q2 Results, Joins Spirit Airlines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
 
Via Benzinga
Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion
From Cerus Corporation
Via Business Wire
Cerus Corporation Celebrates World Blood Donor Day 2024
From Cerus Corporation
Via Business Wire
Cerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor Conference
From Cerus Corporation
Via Business Wire
Zomedica And 3 Other Stocks Under $3 Insiders Are Buying
 
Via Benzinga
ESS Tech And 2 Other Stocks Under $5 Insiders Are Buying
 
Via Benzinga
CERS Stock Earnings: Cerus Meets EPS, Misses Revenue for Q1 2024
CERS stock results show that Cerus met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Cerus Corporation Announces First Quarter 2024 Financial Results
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024
From Cerus Corporation
Via Business Wire
Perion Network Cuts Sales Outlook, Joins Range Resources And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling by around 10 points on Monday. 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life
From Cerus Corporation
Via Business Wire
Cathie Wood's Ark Invest Sells Another Tranche Of Block Shares, Even As Bitcoin Price Stages A Recovery
On Wednesday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Block Inc (NYSE:SQ) amidst Bitcoin (CRYPTO: BTC) prices recovering. 
Via Benzinga
Why Blood Components-Focused Cerus Stock Is Rising Tuesday
Cerus reports results from the ReCePI Phase 3 trial for INTERCEPT Red Blood Cells, meeting the primary efficacy endpoint in cardiac surgery patients. The safety profile is also favorable. Expect FDA... 
Via Benzinga
Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients
From Cerus Corporation
Via Business Wire
Cathie Wood's Ark Invest Sells Coinbase Shares As Bitcoin Hits Yet Another All-Time New High, Buys Stock Of This Social Media Company
On Wednesday, Cathie Wood-led Ark Invest made significant trades involving Coinbase Global Inc (NASDAQ:COIN) and Pinterest Inc (NYSE:PINS). 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.